IL-7 adjuvant treatment enhances long-term tumor antigen-specific CD8 + T-cell responses after immunization with recombinant lentivector

Blood

Volumn 113, Issue 26, 2009, Pages 6629-6637

  Colombetti, Sara ^a   Lévy, Frédéric ^a   Chapatte, Laurence ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 7 RECEPTOR ALPHA; LENTIVIRUS VECTOR; PROTEIN BCL 2; RECOMBINANT INTERLEUKIN 7; CANCER VACCINE; GAMMA INTERFERON; H 2KB PROTEIN, MOUSE; H-2KB PROTEIN, MOUSE; H2 ANTIGEN; HLA A ANTIGEN; HLA A*0201 ANTIGEN; HLA-A*0201 ANTIGEN; IL7 PROTEIN, HUMAN; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; INTERLEUKIN 7 RECEPTOR, ALPHA CHAIN; INTERLEUKIN-7 RECEPTOR, ALPHA CHAIN; RECOMBINANT PROTEIN; SUBUNIT VACCINE; T LYMPHOCYTE RECEPTOR;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; EFFECTOR CELL; IMMUNIZATION; IN VIVO STUDY; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; UPREGULATION; ANIMAL; BIOSYNTHESIS; DRUG EFFECT; GENE VECTOR; GENETICS; GERMFREE ANIMAL; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LENTIVIRINAE; METABOLISM;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; GENETIC VECTORS; H-2 ANTIGENS; HLA-A ANTIGENS; HUMANS; IMMUNIZATION; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; INTERLEUKIN-7; LENTIVIRUS; MICE; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, INTERLEUKIN-7; RECOMBINANT PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS; T-CELL ANTIGEN RECEPTOR SPECIFICITY; UP-REGULATION; VACCINES, SUBUNIT;

EID: 69249230925     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-05-155309     Document Type: Article

References (37)

1. Bachmann MF, Beerli RR, Agnellini P, Wolint P, Schwarz K, Oxenius A. Long-lived memory CD8+ T cells are programmed by prolonged antigen exposure and low levels of cellular activation. Eur J Immunol. 2006;36:842-854.
2. Williams MA, Bevan MJ. Shortening the infectious period does not alter expansion of CD8 T cells but diminishes their capacity to differentiate into memory cells. J Immunol. 2004;173: 6694-6702.
3. Haring JS, Badovinac VP, Harty JT. Inflaming the CD8+ T cell response. Immunity. 2006;25:19-29.
4. Kaech SM, Wherry EJ, Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol. 2002; 2:251-262. (Pubitemid 37323225)
5. Mescher MF, Curtsinger JM, Agarwal P, et al. Signals required for programming effector and memory development by CD8+ T cells. Immunol Rev. 2006;211:81-92. (Pubitemid 43882963)
6. Hou S, Hyland L, Ryan KW, Portner A, Doherty PC. Virus-specific CD8+ T-cell memory determined by clonal burst size. Nature. 1994;369:652-654. (Pubitemid 24199468)
7. Marzo AL, Klonowski KD, Le Bon A, Borrow P, Tough DF, Lefrancois L. Initial T cell frequency dictates memory CD8+ T cell lineage commitment. Nat Immunol. 2005;6:793-799. (Pubitemid 43090465)
8. Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol. 2003;4:1191-1198. (Pubitemid 37540688)
9. Huster KM, Busch V, Schiemann M, et al. Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets. Proc Natl Acad Sci U S A. 2004;101:5610-5615. (Pubitemid 38481204)
10. Jiang Q, Li WQ, Aiello FB, et al. Cell biology of IL-7, a key lymphotrophin. Cytokine Growth Factor Rev. 2005;16:513-533. (Pubitemid 41022015)
11. Schluns KS, Kieper WC, Jameson SC, Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol. 2000;1:426-432.
12. Surh CD, Sprent J. Regulation of mature T cell homeostasis. Semin Immunol. 2005;17:183-191.
13. Boise LH, Minn AJ, June CH, Lindsten T, Thompson CB. Growth factors can enhance lymphocyte survival without committing the cell to undergo cell division. Proc Natl Acad Sci U S A. 1995;92:5491-5495.
14. Li WQ, Jiang Q, Khaled AR, Keller JR, Durum SK. Interleukin-7 inactivates the pro-apoptotic protein Bad promoting T-cell survival. J Biol Chem. 2004; 279:29160-29166. (Pubitemid 38915789)
15. Cayeux S, Beck C, Aicher A, Dorken B, Blankenstein T. Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines. Eur J Immunol. 1995;25:2325-2331.
16. Sin JI, Kim J, Pachuk C, Weiner DB. Interleukin 7 can enhance antigen-specific cytotoxic-T-lymphocyte and/or Th2-type immune responses in vivo. Clin Diagn Lab Immunol. 2000;7:751-758. (Pubitemid 30695512)
17. Maeurer MJ, Trinder P, Hommel G, et al. Interleukin-7 or interleukin-15 enhances survival of Mycobacterium tuberculosis-infected mice. Infect Immun. 2000;68:2962-2970. (Pubitemid 30253878)
18. Melchionda F, Fry TJ, Milliron MJ, McKirdy MA, Tagaya Y, Mackall CL. Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool. J Clin Invest. 2005;115:1177-1187. (Pubitemid 40629036)
19. Esslinger C, Chapatte L, Finke D, et al. In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responses. J Clin Invest. 2003;111:1673-1681.
20. Chapatte L, Colombetti S, Cerottini JC, Levy F. Efficient induction of tumor antigen-specific CD8+ memory T cells by recombinant lentivector. Cancer Res. 2006;66:1155-1160. (Pubitemid 43165985)
21. Vitiello A, Marchesini D, Furze J, Sherman LA, Chesnut RW. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric humanmouse class I major histocompatibility complex. J Exp Med. 1991;173:1007-1015.
22. Levy F, Johnsson N, Rumenapf T, Varshavsky A. Using ubiquitin to follow the metabolic fate of a protein. Proc Natl Acad Sci U S A. 1996;93:4907-4912. (Pubitemid 26162845)
23. Esslinger C, Romero P, MacDonald HR. Efficient transduction of dendritic cells and induction of a T-cell response by third-generation lentivector. Hum Gene Ther. 2002;13:1091-1100. (Pubitemid 34717855)
24. Dull T, Zufferey R, Kelly M, et al. A third-generation lentivirus vector with a conditional packaging system. J Virol. 1998;72:8463-8471. (Pubitemid 28471781)
25. Valmori D, Fonteneau JF, Lizana CM, et al. Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues. J Immunol. 1998; 160:1750-1758. (Pubitemid 28110836)
26. Park JH, Adoro S, Lucas PJ, et al. "Coreceptor tuning": cytokine signals transcriptionally tailor CD8 coreceptor expression to the self-specificity of the TCR. Nat Immunol. 2007;8:1049-1059.
27. Vella AT, Dow S, Potter TA, Kappler J, Marrack P. Cytokine-induced survival of activated T cells in vitro and in vivo. Proc Natl Acad Sci U S A. 1998; 95:3810-3815. (Pubitemid 28173211)
28. Park JH, Yu Q, Erman B, et al. Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T-cell survival. Immunity. 2004;21:289-302. (Pubitemid 39094057)
29. Overwijk WW, Tsung A, Irvine KR, et al. gp100/ pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand. J Exp Med. 1998;188:277-286.
30. Lacombe MH, Hardy MP, Rooney J, Labrecque N. IL-7 receptor expression levels do not identify CD8+ memory T lymphocyte precursors following peptide immunization. J Immunol. 2005;175: 4400-4407. (Pubitemid 41361975)
31. Kaech SM, Hemby S, Kersh E, Ahmed R. Molecular and functional profiling of memory CD8 T cell differentiation. Cell. 2002;111:837-851. (Pubitemid 36106405)
32. Lang KS, Recher M, Navarini AA, et al. Inverse correlation between IL-7 receptor expression and CD8 T cell exhaustion during persistent antigen stimulation. Eur J Immunol. 2005;35:738-745. (Pubitemid 40425529)
33. Xue HH, Kovanen PE, Pise-Masison CA, et al. IL-2 negatively regulates IL-7 receptor alpha chain expression in activated T lymphocytes. Proc Natl Acad Sci U S A. 2002;99:13759-13764.
34. Fuller MJ, Hildeman DA, Sabbaj S, et al. Cutting edge: emergence of CD127high functionally competent memory T cells is compromised by high viral loads and inadequate T cell help. J Immunol. 2005;174:5926-5930. (Pubitemid 40663777)
35. Pellegrini M, Bouillet P, Robati M, Belz GT, Davey GM, Strasser A. Loss of Bim increases T cell production and function in interleukin 7 receptor-deficient mice. J Exp Med. 2004;200:1189-1195. (Pubitemid 39507058)
36. Joshi NS, Cui W, Chandele A, et al. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity. 2007;27:281-295. (Pubitemid 47284924)
37. Morrot A, Cockburn IA, Overstreet M, Rodriguez D, Zavala F. Protective CD8+ T cells induced by malaria sporozoites do not undergo modulation of interleukin-7 receptor expression. Infect Immun. 2006;74:2495-2497.